Rockwell Medical, Inc. SEC filings RMTI

Rockwell Medical, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 29, 2009. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

Rockwell Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Nov 3, 2026 Nov 2, 2026
8-K Current report
Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Other events
Jul 20, 2026 Jul 20, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 29, 2026 Jun 24, 2026
8-K Current report
Shareholder vote results
Jun 15, 2026 Jun 12, 2026
DEFA14A Additional proxy material May 11, 2026 —
8-K Current report
Listing notice
May 8, 2026 May 8, 2026
8-K Current report
Regulation FD disclosure
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
PRE 14A Preliminary proxy statement Apr 20, 2026 Apr 20, 2026
8-K Current report
Regulation FD disclosure
Mar 26, 2026 Mar 26, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
8-K Current report
Results of operations
Jan 20, 2026 Jan 20, 2026
8-K Current report
Other events
Jan 5, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Nov 18, 2025 Nov 17, 2025
8-K Current report
Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Officer or director change
Sep 29, 2025 Sep 23, 2025
S-8 Employee stock plan registration Aug 14, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Shareholder vote results
May 20, 2025 May 20, 2025
8-K Current report
Regulation FD disclosure
May 12, 2025 May 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 14, 2025 May 20, 2025
8-K Current report
Regulation FD disclosure
Mar 20, 2025 Mar 20, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
8-K Current report
Officer or director change
Dec 12, 2024 Dec 10, 2024
8-K Current report
Other events
Nov 13, 2024 Nov 13, 2024
424B5 Prospectus supplement Nov 13, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
EFFECT Filing Oct 21, 2024 —
CORRESP Letter to the SEC Oct 17, 2024 —
CORRESP Letter to the SEC Oct 17, 2024 —
UPLOAD Letter from the SEC Oct 15, 2024 —
S-8 Employee stock plan registration Oct 8, 2024 —
S-3 Shelf registration Oct 8, 2024 —
8-K Current report
Regulation FD disclosure
Aug 8, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jul 15, 2024 Jul 12, 2024
8-K Current report
Shareholder vote results
May 23, 2024 May 21, 2024
8-K Current report
Regulation FD disclosure
May 14, 2024 May 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
ARS Annual report to shareholders Apr 15, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 15, 2024 May 21, 2024
10-K Annual report Mar 21, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Mar 21, 2024 Mar 21, 2024
8-K Current report
Results of operations
Mar 21, 2024 Mar 21, 2024
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 8, 2024
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Other events
Jan 8, 2024 Jan 2, 2024
8-K Current report
Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Officer or director change
Oct 17, 2023 Oct 16, 2023
8-K Current report
Material agreement
Sep 21, 2023 Sep 18, 2023
8-K Current report
Officer or director change
Sep 15, 2023 Sep 13, 2023
8-K Current report
Regulation FD disclosure
Sep 12, 2023 Sep 12, 2023
EFFECT Filing Aug 22, 2023 —
CORRESP Letter to the SEC Aug 21, 2023 —
UPLOAD Letter from the SEC Aug 18, 2023 —
S-8 Employee stock plan registration Aug 15, 2023 —
S-3 Shelf registration Aug 15, 2023 —
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure, Other events
Jul 11, 2023 Jul 10, 2023
8-K Current report
Shareholder vote results
May 23, 2023 May 23, 2023
8-K Current report
Regulation FD disclosure
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
ARS Annual report to shareholders Apr 17, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 17, 2023 May 23, 2023
8-K/A Amended current report
Auditor change
Apr 14, 2023 Apr 7, 2023
8-K Current report
Auditor change
Apr 13, 2023 Apr 7, 2023
8-K Current report
Regulation FD disclosure
Apr 10, 2023 Apr 10, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Regulation FD disclosure
Feb 2, 2023 Feb 1, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
S-8 Employee stock plan registration Aug 16, 2022 —
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
424B5 Prospectus supplement Jul 26, 2022 —
EFFECT Filing Jul 22, 2022 —
CORRESP Letter to the SEC Jul 20, 2022 —
UPLOAD Letter from the SEC Jul 19, 2022 —
S-3 Shelf registration Jul 14, 2022 —
424B5 Prospectus supplement Jul 7, 2022 —
EFFECT Filing Jul 5, 2022 —
CORRESP Letter to the SEC Jun 30, 2022 —
UPLOAD Letter from the SEC Jun 29, 2022 —
S-1 Registration statement Jun 22, 2022 —
8-K Current report
Unregistered share sale, Officer or director change, Other events
Jun 22, 2022 Jun 16, 2022
8-K Current report
Regulation FD disclosure
Jun 13, 2022 Jun 13, 2022
8-K Current report
Material agreement, Unregistered share sale
Jun 2, 2022 May 30, 2022
424B5 Prospectus supplement Jun 1, 2022 —
8-K Current report
Regulation FD disclosure
May 20, 2022 May 20, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
May 13, 2022 May 13, 2022
8-K Current report
Shareholder vote results
May 9, 2022 May 9, 2022
8-K Current report
Material agreement
Apr 11, 2022 Apr 8, 2022
424B5 Prospectus supplement Apr 8, 2022 —
DEF 14A Proxy statement Apr 8, 2022 May 9, 2022
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Apr 8, 2022 Apr 6, 2022
10-K Annual report Apr 8, 2022 Dec 31, 2021
NT 10-K Filing Apr 1, 2022 Dec 31, 2021
PRE 14A Preliminary proxy statement Mar 21, 2022 May 9, 2022
8-K Current report
Officer or director change
Mar 21, 2022 Mar 20, 2022
8-K Current report
Officer or director change
Mar 18, 2022 Mar 14, 2022
8-K Current report
Regulation FD disclosure
Jan 5, 2022 Jan 5, 2022
8-K Current report
Other events
Dec 14, 2021 Dec 14, 2021
8-K Current report
Listing notice
Dec 10, 2021 Dec 9, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
EFFECT Filing Oct 8, 2021 —
CORRESP Letter to the SEC Oct 6, 2021 —
UPLOAD Letter from the SEC Oct 5, 2021 —
S-3 Shelf registration Sep 30, 2021 —
8-K Current report
Material agreement, New debt
Sep 30, 2021 Sep 24, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 16, 2021 Aug 16, 2021
8-K Current report
Shareholder vote results
Jun 21, 2021 Jun 17, 2021
8-K Current report
Listing notice
Jun 17, 2021 Jun 11, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
DEF 14A Proxy statement Apr 30, 2021 Jun 17, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 31, 2021 Mar 31, 2021
8-K Current report
Officer or director change
Jan 25, 2021 Jan 19, 2021
8-K Current report
Officer or director change
Dec 15, 2020 Dec 11, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Bylaw or fiscal year change
Nov 5, 2020 Nov 1, 2020
8-K Current report
Material agreement
Sep 25, 2020 Sep 23, 2020
424B5 Prospectus supplement Sep 25, 2020 —
8-K Current report
Regulation FD disclosure
Sep 24, 2020 Sep 24, 2020
8-K Current report
Officer or director change, Other events
Sep 17, 2020 Sep 15, 2020
8-K Current report
Other events
Sep 9, 2020 Sep 9, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K/A Amended current report
Other events
Jul 22, 2020 Jun 19, 2020
8-K Current report
Regulation FD disclosure
Jul 13, 2020 Jul 13, 2020
8-K Current report
Regulation FD disclosure
Jun 29, 2020 Jun 29, 2020
8-K Current report
Other events
Jun 19, 2020 Jun 19, 2020
8-K Current report
Officer or director change
Jun 10, 2020 Jun 10, 2020
S-8 Employee stock plan registration Jun 2, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2020 May 21, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEFA14A Additional proxy material May 7, 2020 —
DEF 14A Proxy statement Apr 20, 2020 May 18, 2020
8-K Current report
Officer or director change, Other events
Apr 20, 2020 Apr 20, 2020
8-K Current report
Officer or director change
Apr 1, 2020 Apr 1, 2020
8-K Current report
Other events
Mar 27, 2020 Mar 27, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Mar 20, 2020 Mar 16, 2020
S-8 Employee stock plan registration Mar 17, 2020 —
10-K Annual report Mar 17, 2020 Dec 31, 2019
NT 10-K Filing Mar 17, 2020 Mar 16, 2020
8-K Current report
Results of operations
Mar 12, 2020 Mar 12, 2020
8-K Current report
Officer or director change
Mar 2, 2020 Feb 28, 2020
8-K Current report
Other events
Feb 21, 2020 Feb 19, 2020
8-K Current report
Material agreement, Results of operations
Feb 6, 2020 Feb 3, 2020
424B5 Prospectus supplement Feb 5, 2020 —
424B5 Prospectus supplement Feb 3, 2020 —
8-K Current report
Regulation FD disclosure
Jan 15, 2020 Jan 15, 2020
8-K Current report
Other events
Jan 15, 2020 Jan 14, 2020
8-K Current report
Officer or director change
Jan 9, 2020 Jan 9, 2020
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 11, 2019
8-K Current report
Results of operations
Oct 25, 2019 Oct 24, 2019
8-K Current report
Officer or director change
Oct 22, 2019 Oct 16, 2019
8-K Current report
Officer or director change
Sep 6, 2019 Sep 5, 2019
8-A12G/A Filing Aug 30, 2019 —
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Aug 30, 2019 Aug 28, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Material agreement
Aug 7, 2019 Aug 1, 2019
8-K Current report
Other events
Jul 30, 2019 Jul 29, 2019
8-K Current report
Other events
Jul 11, 2019 Jul 9, 2019
8-K Current report
Other events
Jul 2, 2019 Jun 28, 2019
8-K Current report
Other events
Jul 2, 2019 Jun 28, 2019
8-K/A Amended current report
Shareholder vote results
Jun 28, 2019 Jun 6, 2019
8-K Current report
Material agreement
Jun 20, 2019 Jun 17, 2019
8-K Current report
Officer or director change
Jun 19, 2019 Jun 14, 2019
424B5 Prospectus supplement Jun 19, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RMTI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wixom, MI
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1041024
Former names
ROCKWELL MEDICAL TECHNOLOGIES INC (until Jun 14, 2012)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.